Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Thyroid Gland Disorder Treatment Market

Thyroid Gland Disorder Treatment Market Share

Report ID: GMI4214
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Thyroid Gland Disorder Treatment Market Share

The thyroid gland disorder treatment industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Thyroid Gland Disorder Treatment Market Companies

Some of the eminent market participants operating in the thyroid gland disorder treatment industry include:

Abbott Laboratories
AbbVie Inc.
Aspen Pharmacare Holdings Limited
Glenmark Pharmaceuticals Ltd.
Lannett Company, Inc.
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Limited

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Thyroid gland disorder treatment market size was USD 2.4 billion in 2023 and is expected to reach over USD 3.3 billion by 2032 owing to the technological advancements like improved pharmaceutical drug delivery worldwide.

The levothyroxine segment is expected to record USD 1.6 billion by 2032 due to serving as the first-line therapy due to its effectiveness, affordability, and accessibility.

North America thyroid gland disorder treatment industry held 40.7% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to presence of highly developed healthcare infrastructure with state-of-the-art facilities and advanced medical technologies in the region.

AbbVie Inc., Aspen Pharmacare Holdings Limited, Glenmark Pharmaceuticals Ltd., Lannett Company, Inc., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries Limited, are some of the major thyroid gland disorder treatment companies worldwide.